OBI Pharma (ROCO:4174) 3-Year EBITDA Growth Rate : 10.80% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma 3-Year EBITDA Growth Rate?

OBI Pharma's EBITDA per Share for the three months ended in Mar. 2024 was NT$-2.22.

During the past 3 years, the average EBITDA Per Share Growth Rate was 10.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of OBI Pharma was 10.80% per year. The lowest was -46.50% per year. And the median was -7.45% per year.

Competitive Comparison of OBI Pharma's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, OBI Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OBI Pharma's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OBI Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where OBI Pharma's 3-Year EBITDA Growth Rate falls into.

OBI Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

OBI Pharma (ROCO:4174) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

OBI Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of OBI Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

OBI Pharma (ROCO:4174) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, Room. 1907, 19th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.obipharma.com

OBI Pharma Inc is part of the healthcare sector. The company and its subsidiaries are engaged in new drug research. Its focus is on the unmet medical need in challenging diseases throughout the world, such as cancer. OBI strives to improve health and the quality of life through cost-effective therapeutics. The Group has four reportable segments, which are the anti-cancer new drug segment, bispecific monoclonal antibody new drug segment, botulinum toxin new drug segment, and CDMO segment.

OBI Pharma (ROCO:4174) Headlines

No Headlines